Alphatec (ATEC) Moves 9.1% Higher: Will This Strength Last?

Company Overview - Alphatec (ATEC) shares increased by 9.1% to $10.88 in the last trading session, with a higher-than-average trading volume, compared to a 3.6% gain over the past four weeks [1] - The company is part of the Zacks Medical - Instruments industry, which includes other companies like DexCom (DXCM) [4] Financial Performance - For the fourth quarter of 2024, Alphatec expects total revenue between$ 175.5 million and $177.0 million, while full-year 2024 revenue is projected to be between$ 610.3 million and $611.8 million, reflecting a 27% year-over-year increase [2] - The Zacks Consensus Estimate for fiscal 2024 revenue indicates a growth of 25.5% [2] - The upcoming quarterly report is anticipated to show a loss of$ 0.18 per share, which is a 51.4% year-over-year change, with revenues expected to be $170.5 million, up 23.6% from the previous year [3] Earnings Estimates - The consensus EPS estimate for Alphatec has been revised 19.2% lower over the last 30 days, which typically does not correlate with price appreciation [4] - The stock currently holds a Zacks Rank of 2 (Buy), indicating a positive outlook despite the recent downward revision in earnings estimates [4]